HI HB1805 | 2020 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 17 2020 - 25% progression
Action: 2020-02-18 - Bill scheduled to be heard by CPC on Tuesday, 02-25-20 2:00PM in House conference room 329.
Pending: House Consumer Protection & Commerce Committee
Hearing: Feb 25 @ 2:00 pm in Conference Room 329
Text: Latest bill text (Introduced) [HTML]

Summary

Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To Prescription Drugs.

Sponsors


History

DateChamberAction
2020-02-18HouseBill scheduled to be heard by CPC on Tuesday, 02-25-20 2:00PM in House conference room 329.
2020-02-10HouseRe-referred to CPC, referral sheet 23
2020-01-21HouseReferred to HLT, CPC, referral sheet 2
2020-01-17HouseIntroduced and Pass First Reading.
2020-01-16HousePending introduction.

Subjects


Hawaii State Sources


Bill Comments

feedback